Abstract
Synthetic cannabinoids (SCs) are known to have structural or positional isomers. While regulations on synthetic drugs like synthetic cathinones and SCs have been placed worldwide for the ever-growing variety of new designer drugs, laws may not necessarily be applicable to their isomers. Toxicological differences may also exist among isomers for which most new designer drugs are still uninvestigated; thus, isomer differentiation becomes of forensic importance. The aim of this study was to differentiate the regioisomers of alkyl-substituted naphthoylindole-type SCs JWH-122 and JWH-210. Reference standards of the two drugs and their regioisomers were analyzed by gas chromatography–electron ionization-mass spectrometry (GC–EI-MS) first in full scan mode. Isomers that produced identical EI spectra were further analyzed by GC-tandem mass spectrometry (MS/MS) by selecting appropriate precursor ions. For JWH-210, comparison of the product ion spectra and the relative ion intensity ratios obtained from precursor ions at m/z 312 and 183 enabled differentiation between all seven regioisomers. Complete isomeric differentiation by MS/MS analysis was not attainable for JWH-122; however, combining chromatographic results with MS/MS analysis results enabled differentiation for all isomers. Two basic fragmentation pathways were speculated for both SCs; for JWH-210, fragmentation pathway tendencies differed among the isomers, resulting in their distinguishability. Our results demonstrated that the difference between the methyl (JWH-122) and ethyl (JWH-210) group substituents contributed to fragmentation pathway tendency differences and further distinguishability between the regioisomers. Functional group differences, especially their stereochemistries, were indicated to be critical factors in positional isomer differentiation by GC-MS/MS.
Similar content being viewed by others
References
Chung H, Lee J, Kim E (2015) Trends of novel psychoactive substances (NPSs) and their fatal cases. Forensic Toxicol 34:1–11
Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009) Spice: a never ending story? Forensic Sci Int 191:58–63
German CL, Fleckenstein AE, Hanson GR (2014) Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 97:2–8
Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N (2009) ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832–837
Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2014) Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. Drug Test Anal 6:832–839
EMCDDA (2009) Understanding the ‘Spice’ phenomenon. Lisbon. http://www.emcdda.europa.eu/system/files/publications/537/Spice-Thematic-paper-final-version.pdf. Accessed November 2015.
Huffman JW, Zengin G, Wu M-J, Lu J, Hynd G, Bushell K, Thompson ALS, Bushell S, Tartal C, Hurst DP, Reggio PH, Selley DE, Cassidy MP, Wiley JL, Martin BR (2005) Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorg Med Chem 13:89–112
Huffman JW (2009) Cannabimimetic indoles, pyrroles, and indenes: structure—activity relationships and receptor interactions. In: Reggio PH (ed) The cannabinoid receptors. Humana Press, New York, pp 49–94
Atwood BK, Huffman J, Straiker A, Mackie K (2010) JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist. Br J Pharmacol 160:585–593
Zaitsu K, Hayashi Y, Suzuki K, Nakayama H, Hattori N, Takahara R, Kusano M, Tsuchihashi H, Ishii A (2015) Metabolome disruption of the rat cerebrum induced by the acute toxic effects of the synthetic cannabinoid MAM-2201. Life Sci 137:49–55
Clark CR, DeRuiter J (1996) Chromatographic and mass spectrometry methods for the differentiation of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine from regioisomeric derivatives. J Chromatogr Sci 34:230–237
Cody JT, Valtier S (2002) Differentiation of the 2,3-methylenedioxy regioisomer of 3,4-MDMA (Ecstasy) by gas chromatography-mass spectrometry. J Anal Toxicol 26:537–539
Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata Y, Miyamoto K, Kasuya F, Inoue H (2013) Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry. Forensic Toxicol 31:241–250
Thaxton A, Belal TS, Smith F, DeRuiter J, Abdel-Hay KM, Clark CR (2015) GC-MS studies on the six naphthoyl-substituted 1-n-pentyl-indoles: JWH-018 and five regioisomeric equivalents. Forensic Sci Int 252:107–113
Zaitsu K, Katagi M, Kamata H, Miki A, Tsuchihashi H (2008) Discrimination and identification of regioisomeric β-keto analogues of 3,4-methylenedioxyamphetamines by gas chromatography-mass spectrometry. Forensic Toxicol 26:45–51
Debruyne D, Le Boisselier R (2015) Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Subst Abuse Rehabil 6:113–129
Aalberg L, DeRuiter J, Noggle FT, Sippola E, Clark CR (2003) Chromatographic and spectroscopic methods of identification for the side-chain regioisomers of 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB. J Chromatogr Sci 41:227–233
Awad T, Belal T, Maher HM, DeRuiter J, Clark CR (2010) GC-MS studies on side chain regioisomers related to substituted methylenedioxyphenethylamines: MDEA, MDMMA, and MBDB. J Chromatogr Sci 48:726–732
Awad T, DeRuiter J, Belal T, Clark CR (2009) GC and mass spectral studies on acylated side chain regioisomers of 3-methoxy-4-methyl-phenethylamine and 4-methoxy-3-methyl-phenethylamine. J Chromatogr Sci 47:279–286
Borth S, Hänsel W, Rösner P, Junge T (2000) Regioisomeric differentiation of 2,3- and 3,4-methylenedioxy ring-substituted phenylalkylamines by gas chromatography/tandem mass spectrometry. J Mass Spectrom 35:705–710
Borth S, Hänsel W, Rösner P, Junge T (2000) Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS. Forensic Sci Int 114:139–153
Inoue H, Negishi S, Nakazono Y, Iwata Y, Tsujikawa K, Ohtsuru O, Miyamoto K, Yamashita T, Kasuya F (2016) Differentiation of ring-substituted bromoamphetamine analogs by gas chromatography–tandem mass spectrometry. Forensic Toxicol 34:125–132
Kusano M, Zaitsu K, Nakayama H, Nakajima J, Hisatsune K, Moriyasu T, Matsuta S, Katagi M, Tsuchihashi H, Ishii A (2015) Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS. J Mass Spectrom 50:586–591
Negishi S, Nakazono Y, Iwata Y, Kanamori T, Tsujikawa K, Kuwayama K, Yamamuro T, Miyamoto K, Yamashita T, Kasuya F, Inoue H (2015) Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography–chemical ionization-tandem mass spectrometry. Forensic Toxicol 33:338–347
Westphal F, Junge T (2012) Ring positional differentiation of isomeric N-alkylated fluorocathinones by gas chromatography/tandem mass spectrometry. Forensic Sci Int 223:97–105
Westphal F, Rösner P, Junge T (2010) Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry. Forensic Sci Int 194:53–59
Zaitsu K, Miyagawa H, Sakamoto Y, Matsuta S, Tsuboi K, Nishioka H, Katagi M, Sato T, Tatsuno M, Tsuchihashi H, Suzuki K, Ishii A (2013) Mass spectrometric differentiation of the isomers of mono-methoxyethylamphetamines and mono-methoxydimethylamphetamines by GC-EI-MS-MS. Forensic Toxicol 31:292–300
Ernst L, Schiebel H-M, Theuring C, Lindigkeit R, Beuerle T (2011) Identification and characterization of JWH-122 used as new ingredient in “Spice-like” herbal incenses. Forensic Sci Int 208:e31–e35
Hermanns-Clausen M, Kithinji J, Spehl M, Angerer V, Franz F, Eyer F, Auwärter V (2016) Adverse effects after the use of JWH-210—a case series from the EU Spice II plus project. Drug Test Anal. doi:10.1002/dta.1936
Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108:534–544
Hermanns-Clausen M, Kneisel S, Hutter M, Szabo B, Auwärter V (2013) Acute intoxication by synthetic cannabinoids—four case reports. Drug Test Anal 5:790–794
Thaxton A, Belal TS, Smith F, DeRuiter J, Abdel-Hay KM, Clark CR (2015) Mass spectral studies on 1-n-pentyl-3-(1-naphthoyl)indole (JWH-018), three deuterium-labeled analogues and the inverse isomer 1-naphthoyl-3-n-pentylindole. Rapid Commun Mass Spectrom 29:871–877
Acknowledgments
This study was supported by the Japan Society for the Promotion of Sciences (JSPS) Grand-in-Aid for Scientific Research (KAKENHI) Grant numbers 26893105 and 15H02530.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no financial or other relations that could lead to a conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Kusano, M., Yamanaka, M., Zaitsu, K. et al. Regioisomeric differentiation of the alkyl-substituted synthetic cannabinoids JWH-122 and JWH-210 by GC-EI-MS/MS. Forensic Toxicol 34, 304–315 (2016). https://doi.org/10.1007/s11419-016-0317-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11419-016-0317-x